Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Additive Duloxetine for Cancer-Related Neuropathic Pain Nonresponsive or Intolerant to Opioid-Pregabalin Therapy: A Randomized Controlled Trial (JORTC-PAL08).
Matsuoka H, Iwase S, Miyaji T, Kawaguchi T, Ariyoshi K, Oyamada S, Satomi E, Ishiki H, Hasuo H, Sakuma H, Tokoro A, Shinomiya T, Otani H, Ohtake Y, Tsukuura H, Matsumoto Y, Hasegawa Y, Kataoka Y, Otsuka M, Sakai K, Matsuda Y, Morita T, Koyama A, Yamaguchi T. Matsuoka H, et al. Among authors: oyamada s. J Pain Symptom Manage. 2019 Oct;58(4):645-653. doi: 10.1016/j.jpainsymman.2019.06.020. Epub 2019 Jun 26. J Pain Symptom Manage. 2019. PMID: 31254640 Free article. Clinical Trial.
Morphine for dyspnoea in chronic obstructive pulmonary disease: a before-after efficacy study.
Matsuda Y, Morita T, Matsumoto H, Hosoi K, Kusama K, Kohashi Y, Morishita H, Kaku S, Ariyoshi K, Oyamada S, Inoue Y, Iwase S, Yamaguchi T, Nishikawa M. Matsuda Y, et al. Among authors: oyamada s. BMJ Support Palliat Care. 2021 Dec;11(4):427-432. doi: 10.1136/bmjspcare-2019-001929. Epub 2019 Nov 15. BMJ Support Palliat Care. 2021. PMID: 31732660 Clinical Trial.
Predictors of duloxetine response in patients with neuropathic cancer pain: a secondary analysis of a randomized controlled trial-JORTC-PAL08 (DIRECT) study.
Matsuoka H, Iwase S, Miyaji T, Kawaguchi T, Ariyoshi K, Oyamada S, Satomi E, Ishiki H, Hasuo H, Sakuma H, Tokoro A, Matsuda Y, Tahara K, Otani H, Ohtake Y, Tsukuura H, Matsumoto Y, Hasegawa Y, Kataoka Y, Otsuka M, Sakai K, Nakura M, Morita T, Yamaguchi T, Koyama A. Matsuoka H, et al. Among authors: oyamada s. Support Care Cancer. 2020 Jun;28(6):2931-2939. doi: 10.1007/s00520-019-05138-9. Epub 2019 Nov 25. Support Care Cancer. 2020. PMID: 31761974 Clinical Trial.
Predictors of Morphine Efficacy for Dyspnea in Inpatients with Chronic Obstructive Pulmonary Disease: A Secondary Analysis of JORTC-PAL 07.
Matsuda Y, Morita T, Matsumoto H, Hosoi K, Kusama K, Kohashi Y, Morishita H, Kaku S, Ariyoshi K, Oyamada S, Inoue Y, Iwase S, Yamaguchi T, Nishikawa M. Matsuda Y, et al. Among authors: oyamada s. Palliat Med Rep. 2021 Jan 7;2(1):15-20. doi: 10.1089/pmr.2020.0078. eCollection 2021. Palliat Med Rep. 2021. PMID: 34223498 Free PMC article.
Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocol.
Matsuoka H, Clark K, Fazekas B, Oyamada S, Brown L, Ishiki H, Matsuda Y, Hasuo H, Ariyoshi K, Lee J, Le B, Allcroft P, Kochovska S, Fujiwara N, Miyaji T, Lovell M, Agar M, Yamaguchi T, Satomi E, Iwase S, Phillips J, Koyama A, Currow DC. Matsuoka H, et al. Among authors: oyamada s. BMJ Open. 2022 Feb 7;12(2):e050182. doi: 10.1136/bmjopen-2021-050182. BMJ Open. 2022. PMID: 35131817 Free PMC article.
Systemic Opioids for Dyspnea in Cancer Patients: A Real-world Observational Study.
Yamaguchi T, Matsunuma R, Matsuda Y, Tasaki J, Ikari T, Miwa S, Aiki S, Takagi Y, Kiuchi D, Suzuki K, Oyamada S, Ariyoshi K, Kihara K, Mori M. Yamaguchi T, et al. Among authors: oyamada s. J Pain Symptom Manage. 2023 May;65(5):400-408. doi: 10.1016/j.jpainsymman.2022.12.146. Epub 2023 Jan 11. J Pain Symptom Manage. 2023. PMID: 36641006
78 results